Sipra Banerjee Selected Research

methyl 25-hydroxy-3-oxoolean-12-en-28-oate

6/2009	Novel semisynthetic triterpenoid AMR-Me inhibits telomerase activity in human leukemic CEM cells and exhibits in vivo antitumor activity against Dalton's lymphoma ascites tumor.
6/2008	Novel synthetic triterpenoid methyl 25-hydroxy-3-oxoolean-12-en-28-oate induces apoptosis through JNK and p38 MAPK pathways in human breast adenocarcinoma MCF-7 cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sipra Banerjee Research Topics

Disease

10	Neoplasms (Cancer) 01/2018 - 01/2004
8	Breast Neoplasms (Breast Cancer) 01/2018 - 01/2004
7	Carcinoma (Carcinomatosis) 01/2018 - 01/2004
2	Carcinogenesis 06/2009 - 06/2007
1	Colonic Neoplasms (Colon Cancer) 01/2018
1	Stomach Neoplasms (Stomach Cancer) 01/2012
1	Ovarian Neoplasms (Ovarian Cancer) 01/2012
1	Leukemia 06/2009
1	Lymphoma (Lymphomas) 06/2009
1	Ascites 06/2009
1	Adenocarcinoma 06/2008
1	Renal Cell Carcinoma (Grawitz Tumor) 06/2007
1	Microsatellite Instability 01/2004

Drug/Important Bio-Agent (IBA)

6	4- propionyloxy- 4- phenyl- N- methylpiperidineIBA 01/2018 - 01/2004
4	GlycolipidsIBA 08/2009 - 01/2004
3	Pharmaceutical PreparationsIBA 01/2018 - 05/2006
3	RV 538 (PDMP)IBA 01/2018 - 01/2004
3	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 01/2004
3	GlycosyltransferasesIBA 01/2011 - 05/2006
3	GlycosphingolipidsIBA 08/2009 - 01/2004
3	TriterpenesIBA 06/2009 - 01/2007
2	DNA HelicasesIBA 01/2018 - 05/2006
2	GD3 ganglioside (GD(3))IBA 01/2018 - 01/2004
2	Betulinic AcidIBA 01/2018 - 01/2004
2	Tamoxifen FDA LinkGeneric 01/2018 - 01/2004
2	Melphalan (Alkeran)FDA LinkGeneric 01/2018 - 01/2004
2	DNA Polymerase I (Klenow Fragment)IBA 01/2018 - 05/2006
2	DNA Polymerase beta (DNA Polymerase IV)IBA 01/2012 - 06/2007
2	GlycoconjugatesIBA 01/2012 - 01/2004
2	CeramidesIBA 08/2009 - 01/2004
2	methyl 25-hydroxy-3-oxoolean-12-en-28-oateIBA 06/2009 - 06/2008
2	amooraninIBA 06/2008 - 01/2007
1	Indicators and Reagents (Reagents)IBA 01/2018
1	EnzymesIBA 01/2018
1	GD1b gangliosideIBA 01/2018
1	DNA-Directed DNA Polymerase (Polymerases, DNA)IBA 01/2018
1	Cisplatin (Platino)FDA LinkGeneric 01/2011
1	Surface Antigens (Surface Antigen)IBA 08/2009
1	RibonucleoproteinsIBA 06/2009
1	Telomerase (Telomerase Reverse Transcriptase)IBA 06/2009
1	Fas Ligand Protein (Fas Ligand)IBA 06/2008
1	Caspase 9IBA 06/2008
1	p38 Mitogen-Activated Protein KinasesIBA 06/2008
1	Cytochromes c (Cytochrome c)IBA 06/2008
1	Caspase 8 (Caspase-8)IBA 06/2008
1	Proteins (Proteins, Gene)FDA Link 06/2007
1	Plant Preparations (Preparation, Plant)IBA 01/2007
1	CaspasesIBA 01/2007
1	Cytidine Monophosphate (CMP)IBA 05/2006
1	SialyltransferasesIBA 05/2006
1	Insulin (Novolin)FDA Link 01/2004
1	GangliosidesIBA 01/2004
1	Poly AIBA 01/2004
1	Poly GIBA 01/2004
1	Growth Factor ReceptorsIBA 01/2004
1	Transforming Growth Factor beta Receptors (TGF beta Receptors)IBA 01/2004
1	Caspase 3 (Caspase-3)IBA 01/2004

Therapy/Procedure

2	Aftercare (After-Treatment) 08/2009 - 05/2006
1	Drug Therapy (Chemotherapy) 01/2004